Focus on Rubius

This Industry Is Investing Hundreds of Millions of Dollars in Rhode Island


The life sciences industry in Rhode Island is flourishing, and it’s no accident. Across the state, private, public and academic organizations have doubled down on their efforts to stimulate the sector.


The payoff? Leading biotech companies like Rubius Therapeutics and Amgen have recently announced plans to invest hundreds of millions of dollars in the state, in the form of a 135,000-square-foot manufacturing facility and 120,000-square-foot biomanufacturing plant, respectively.


Why Rhode Island? Over on the Rhode Island Inno blog this week, I’m exploring how our state got the recipe just right for biotech, pharma and medical technology companies like Johnson & Johnson, EpiVax, Rubius and Amgen. Go check it out!